5//SEC Filing
INVIVO THERAPEUTICS HOLDINGS CORP. 5
Accession 0001179110-16-017957
CIK 0001292519operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 7:34 PM ET
Size
5.0 KB
Accession
0001179110-16-017957
Insider Transaction Report
Form 5
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Common Stock
2015-12-31$6.12/sh+265$1,622→ 21,693 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK 0001292519
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001292519
Filing Metadata
- Form type
- 5
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 7:34 PM ET
- Size
- 5.0 KB